Sean McLoughlin | CEO
Denteric
Sean brings more than 25 years of experience in the biopharmaceutical industry, spanning early development through to launch and commercial success. At GSK, he led cross-functional teams that delivered two of the industry’s most successful vaccines, Shingrix and Arexvy, and contributed to reshaping treatment approaches in diabetes and cardiovascular disease. Post GSK, he has continued to hold senior leadership roles, most recently as Chief Operating Officer at HilleVax, where he prepared the company for Phase 3 development and commercialization of its norovirus vaccine platform. At Denteric, he applies this same expertise in strategy, execution and team leadership to advance its pipeline.
Appearances:
Day 2 - Wednesday 1st April @ 13:10
5-Minute Presentations - Innovator Showcase
1:10 Dr Julie Zhou, Head of Corporate Development, Delonix Bioworks
1:15 - “A First-in-Class Therapeutic Vaccine for Chronic Inflammation” Sean McLoughlin, CEO, Denteric
1:20 - Dr Ivo Ploeman, Co-Founder & Co-CEO, Praetorian Bio
1:25 - 'Transforming Viral Immune Surveillance & Drug Discovery'Linda D. Chilin, MS, Associate Research Scientist, Athari Biosciences
1:30 Asel Sartbaeva, CEO, Ensilitech
1:35 Dr Robert Ernst, Founder & SAB Chair, TollereBio
1:40 Patty Tawardos, CEO, Donor X
1:45 Luciana Leite, Founder, BCGene
1:50 Sarah-Meryll Buet, CEO, Alkion BioInnovations
1:55 Gregory Smith, CSO & Co-Founder, Thyreos Vaccines
2:00 - "Building the Future of Bacterial Prevention: Advancing Phage Prophylaxis for Cholera" - Dr Minmin Yen, CEO & Co-Founder, PhagePro
2:05 Professor Juliane Bubeck Wardenburg, Founder, Forward Defense LLC
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events